for women

LIFT THE CHEEK1*†‡ Ck1

Ck4

DEFINE THE MANDIBLE

Jw1
ANGLE1§II

C1 ELONGATE THE CHIN1§††

LIFT THE JAWLINE1§¶** Jw4
C2 IMPROVE CHIN HEIGHT1§‡‡
Jw5

Position of the MD Codes™ on the face adapted from de Maio M, 2021.2 The aims that have been provided are specific for the 7-point Shape™ strategy. These recommendations are provided by Dr Maurício de Maio (CRM/SP 69331 RQE 14478) and are based on his extensive clinical and personal experience.

* Using Juvéderm® VOLUMA® with lidocaine;3 Additional aims for each individual code include: †Ck1 aims to lift and define the cheek, give support to the eyebrow and lower eyelid, open the eye, improve sagginess of the cheek and jawline, indirectly improve hollowness in the infraorbital area and tear trough,
indirectly improve prominent nasolabial folds, oral commissures and marionette lines and may aid in creating a slimming and more contoured effect;1 Ck1 curve aims to create structure and definition along the zygomatic arch;1 ‡Ck4 aims to lift the lower cheek and jawline, address the sunken area at the parotid
level and may aid in creating a slimming and more contoured effect.1 § Using Juvéderm® VOLUX™.4 IIJw1 aims to improve mandible projection and widens the face for masculine-looking results.1 ¶Jw4 aims to correct prejowl sulcus and improve submental skin excess.1 ** Jw5 aims to reshape and project the chin
and improve submental skin excess.1 ††C1 aims to open the labio-mental angle, reduce the mental crease, reduce the protrusion of the lower lip and give support to the oral commissure.1 ‡‡C2 aims to improve vertical dimension and make the chin triangular.1 Graphical representation of the MD Codes™ is for
illustrative purposes only. Indications may vary by product and by country; please refer to your local Directions for Use for each product. C: Chin; Ck: Cheek; Jw: Jawline.

1. de Maio M. Aesthet Plast Surg 2021;45(suppl. 1):690-709. doi: 10.1007/s00266-020-01762-7; 2. de Maio M. Aesthet Plast Surg 2021;45:690-709. doi: 10.1007/s00266-020-01762-7; 3. Juvéderm® VOLUMA® with lidocaine Directions for Use. Latest update; 4. Juvéderm® VOLUX™ Directions for Use. Latest update.
 for women

Active number
MD Codes™1 Product Target layer1 Injection device Delivery1 per side (mL)1* Please note1

Ck1 anchor VM2† Supraperiosteal‡ Needle1§ Bolus 0.1 + 0.1 + 0.1II

Ck1 curve VM2† Sub-SMAS Cannula1,4¶ Linear 0.5**

Ck4 VM2† Subcutaneous Cannula1,4¶ Fanning 0.5** Be wary of the parotid gland

C1 VX3† Subcutaneous Cannula1 Fanning 0.5†† Be wary of the sublabial artery

C2 VX3† Subcutaneous Cannula1 Bolus 0.3

Supraperiosteal‡ Needle1§ Bolus 0.5

Jw1 VX 3†
Be wary of the parotid gland
Subcutaneous Cannula1 Fanning 0.5

Jw4 VX3† Subcutaneous Cannula1 Linear 0.5 Be wary of the submental artery

Jw5 VX3† Subcutaneous Cannula1 Linear 0.5 Be wary of the submental artery

For the aim of making the chin more

C21/VX3†/supraperiosteal1‡/needle1§/bolus1/0.3 mL (only midline)1* Be wary of the submental artery1
triangular, consider C2 midline5

Additional consideration for Jw4 Jw41/VX3†/supraperiosteal1‡/needle1§/bolus1/0.3 mL1* Be wary of the submental artery1

These recommendations are provided by Dr Maurício de Maio (CRM/SP 69331 RQE 14478) and are based on his extensive clinical and personal experience. C: Chin; Ck: Cheek; Jw: Jawline; SMAS: superficial muscular aponeurotic system; VM: Juvéderm® VOLUMA® with lidocaine;
VX: Juvéderm® VOLUX™.
* Active numbers represent the minimum volume to be injected in an area represented by a code to deliver a demonstrable result. Actual injection volumes should
be determined by the clinician for each patient. The active number is based on Dr de Maio’s experience with more than 10,000 syringes over a 4-year period.1 1. de Maio M. Aesthetic Plast Surg 2021;45:838–43 (correction). doi: 10.1007/s00266-020-02102-5.
†
Do not inject more than 2 mL of Juvéderm® VOLUX™ or Juvéderm® VOLUMA® with lidocaine per treatment area in a single session.2,3 2. Juvéderm® VOLUMA® with lidocaine Directions for Use. Latest update.
‡
Do not inject into the bone, but rather at the level of the bone.1 3. Juvéderm® VOLUX™ Directions for Use. Latest update.
§
Aspiration is highly recommended when injecting with a needle at the level of the bone.1 4. Mowlds DS and Lambros V. Plast Reconstr Surg 2018;141:1124-9. doi: 10.1097/PRS.0000000000004341.
II
Consider Ck1 as the starting point for treatment with the MD Codes™. Injections in Ck1 are done supraperiosteally and serve as anchors to promote SMAS lifting.1 5. de Maio M. Aesthet Plast Surg 2021;45(suppl. 1):690-709. doi: 10.1007/s00266-020-01762-7.
¶
Use of cannula with Juvéderm® VOLUMA® with lidocaine has been reported in the literature;4 it is not included in the Juvéderm® VOLUMA® with lidocaine
Directions for Use.2
** When treatment of Ck1 anchor and Ck4 or Ck1 curve are combined in the same session, either the active number of Ck4 or Ck1 curve becomes 0.7 mL.1
††
Although the active number for C1 is 0.5 mL, when treatment of C1 is combined with C2, the active number for C1 becomes 0.7 mL, so that the total volume for C1
+ C2 = 1.0 mL (1 syringe).1 Developed and funded by Allergan Aesthetics, an AbbVie company AbbVie B.V./ N.V. l BNL-JUV-220117 l December 2022